JPRN-UMIN000013050
Completed
未知
Angiotensin receptor blocker/Calcium antagonist combination therapy on diurnal blood pressure variation - Angiotensin receptor blocker/Calcium antagonist combination therapy on diurnal blood pressure variation
Jichi Medical University School of Medicine0 sites200 target enrollmentFebruary 3, 2014
ConditionsHypertension
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Hypertension
- Sponsor
- Jichi Medical University School of Medicine
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who meet one of the following criteria are excluded: 1\)Secondary hypertension 2\)Congestive heart failure; onset of acute myocardial infarction in the past 6 month; onset of cerebrovascular disturbance in the past 6 month; current atrial fibrillation or atrioventricular block or severe arrhythmia. 3\)hepatic insufficiency (AST or ALT \>X2 the upper limit of the normal range) , renal insufficiency (serum Crl.\>1\.5mg/dL) 4\)Diabetic patients being treated with aliskiren. 5\)Allergy or drug hypersensitivity. 6\)Lack of the informed consent for any reason (e.g. dementia). 7\)Women suspected of being pregnant. 8\)Patients being ineligible by the attending physicians.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
ACE-inhibitors and Angiotensin two receptor antagonists in IgA nephropathy with mild proteinuriaThe primary aim of the study consists in testing the hypothesis that blockade of the RAS may decrease the risk of developing adverse effects in patients with benign IgAN.Such blockade would first achieved with unique pharmacological class then shifting to the association of the two classes as soon as ineffective blockade is documentedMedDRA version: 9.1Level: SOCClassification code 10038359Term: Renal and urinary disordersEUCTR2005-003885-40-ITAZIENDA OSPEDALIERA PROVINCIALE DI LECCO
Completed
Not Applicable
Angiotensin Converting Enzyme (ACE) inhibition for the preservation of renal function and patient survival in kidney transplantatioChronic kidney disease in renal transplant patientsUrological and Genital DiseasesChronic kidney diseaseISRCTN78129473Ottawa Hospital Research Institute (OHRI) (Canada) - formerly Ottawa Health Research Institute528
Recruiting
Not Applicable
Angiotensin receptor-neprilysin inhibitor in patients with acute myocardial infarction and heart failureAcute myocardial infarctionJPRN-UMIN000046004Chiba University Hospital1,000
Completed
Not Applicable
The role of angiotensine receptor blocker treatment in patients with rheumatoid arthritis: evaluate of endothelial functioRheumatoid arthritisJPRN-UMIN000008536Kawasaki Medical School50
Recruiting
Not Applicable
Management of angiotensin inhibitors during the perioperative period.on-cardiac major surgeryNL-OMON25483niversity Medical Center Utrecht, The Netherlands3,200